The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 03, 2017
Filed:
Jun. 16, 2009
Applicants:
Amarpreet S. Sawhney, Lexington, MA (US);
William H. Ransone, Ii, Waltham, MA (US);
Inventors:
Amarpreet S. Sawhney, Lexington, MA (US);
William H. Ransone, II, Waltham, MA (US);
Assignee:
Incept LLC, Lexington, MA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/10 (2017.01); A61K 31/196 (2006.01); A61K 31/405 (2006.01); A61K 31/4422 (2006.01); A61K 31/4458 (2006.01); A61K 31/496 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01); A61K 9/06 (2006.01); A61K 31/445 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/10 (2013.01); A61K 9/0019 (2013.01); A61K 9/0051 (2013.01); A61K 9/06 (2013.01); A61K 31/196 (2013.01); A61K 31/405 (2013.01); A61K 31/445 (2013.01); A61K 31/4422 (2013.01); A61K 31/4458 (2013.01); A61K 31/496 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01); A61K 9/0048 (2013.01);
Abstract
Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular, intra-ocular, or intra-vitreal site for controlled release of a therapeutic agent.